APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceutical (Oral Route)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Radiopharmaceutical (Oral Route) Industry Growth and Trends Forecast to 2032

31 December 2025114 pages

Choose your research edition.

Industry ResearchRadiopharmaceutical (Oral Route) Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceutical (Oral Route) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Radiopharmaceutical (Oral Route) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceutical (Oral Route) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceutical (Oral Route) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Radiopharmaceutical (Oral Route) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Radiopharmaceutical (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceutical (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceutical (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radiopharmaceutical (Oral Route) include Eli Lilly, Bayer, Triad Isotopes, SIEMENS, Nordion, Navidea, Mallinckrodt, Lantheus and Jubilant Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Radiopharmaceutical (Oral Route) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Radiopharmaceutical (Oral Route) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiopharmaceutical (Oral Route) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiopharmaceutical (Oral Route).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Radiopharmaceutical (Oral Route) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Radiopharmaceutical (Oral Route) Market by Company

Eli Lilly

Bayer

Triad Isotopes

SIEMENS

Nordion

Navidea

Mallinckrodt

Lantheus

Jubilant Pharma

IBA Group

GE Healthcare

Dongcheng

China Isotope & Radiation

Bracco Imaging

Advanced Accelerator Applications

Radiopharmaceutical (Oral Route) Segment by Type

Actinium-225

Holmium-166

Radium-223

Lutetium-177

Other

Radiopharmaceutical (Oral Route) Segment by Application

Oncology

Cardiology

Other

Radiopharmaceutical (Oral Route) Segment by Region

North America

United States

Canada

Europe

v

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceutical (Oral Route) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceutical (Oral Route) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceutical (Oral Route).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceutical (Oral Route) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Radiopharmaceutical (Oral Route) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Actinium-225 Table 2. Major Company of Holmium-166 Table 3. Major Company of Radium-223 Table 4. Major Company of Lutetium-177 Table 5. Major Company of Other Table 6. Global Radiopharmaceutical (Oral Route) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (K Units) Table 8. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type (2021-2026) Table 9. Global Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 10. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type (2021-2026) Table 11. Global Radiopharmaceutical (Oral Route) Price by Type (2021-2026) & (US$/Unit) Table 12. Global Radiopharmaceutical (Oral Route) Sales by Type (2027-2032) & (K Units) Table 13. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type (2027-2032) Table 14. Global Radiopharmaceutical (Oral Route) Sales by Type (2027-2032) & (US$ Million) Table 15. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type (2027-2032) Table 16. Global Radiopharmaceutical (Oral Route) Price by Type (2027-2032) & (US$/Unit) Table 17. North America Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (K Units) Table 18. North America Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (K Units) Table 20. Europe Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (K Units) Table 24. Latin America Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Type (2021-2026) & (US$ Million) Table 27. Radiopharmaceutical (Oral Route) Industry Trends Table 28. Radiopharmaceutical (Oral Route) Industry Drivers Table 29. Radiopharmaceutical (Oral Route) Industry Opportunities and Challenges Table 30. Radiopharmaceutical (Oral Route) Industry Restraints Table 31. Global Radiopharmaceutical (Oral Route) Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company (2021-2026) Table 33. Global Radiopharmaceutical (Oral Route) Sales by Company (2021-2026) & (K Units) Table 34. Global Radiopharmaceutical (Oral Route) Sales Share by Company (2021-2026) Table 35. Global Radiopharmaceutical (Oral Route) Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Radiopharmaceutical (Oral Route) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Radiopharmaceutical (Oral Route) Major Company Production Sites and Headquarters Table 38. Global Radiopharmaceutical (Oral Route) Company, Product Type & Application Table 39. Global Radiopharmaceutical (Oral Route) Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Radiopharmaceutical (Oral Route) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Radiopharmaceutical (Oral Route) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Radiopharmaceutical (Oral Route) Sales by Region (2021-2026) & (K Units) Table 44. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Region (2021-2026) Table 45. Global Radiopharmaceutical (Oral Route) Sales by Region (2021-2026) & (US$ Million) Table 46. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Region (2021-2026) Table 47. Global Radiopharmaceutical (Oral Route) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Radiopharmaceutical (Oral Route) Sales by Region (2027-2032) & (K Units) Table 49. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Region (2027-2032) Table 50. Global Radiopharmaceutical (Oral Route) Sales by Region (2027-2032) & (US$ Million) Table 51. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Region (2027-2032) Table 52. Global Radiopharmaceutical (Oral Route) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Radiopharmaceutical (Oral Route) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (K Units) Table 55. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application (2021-2026) Table 56. Global Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 57. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application (2021-2026) Table 58. Global Radiopharmaceutical (Oral Route) Price by Application (2021-2026) & (US$/Unit) Table 59. Global Radiopharmaceutical (Oral Route) Sales by Application (2027-2032) & (K Units) Table 60. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application (2027-2032) Table 61. Global Radiopharmaceutical (Oral Route) Sales by Application (2027-2032) & (US$ Million) Table 62. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application (2027-2032) Table 63. Global Radiopharmaceutical (Oral Route) Price by Application (2027-2032) & (US$/Unit) Table 64. North America Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (K Units) Table 65. North America Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (K Units) Table 67. Europe Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (K Units) Table 71. Latin America Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Application (2021-2026) & (US$ Million) Table 74. Eli Lilly Company Information Table 75. Eli Lilly Business Overview Table 76. Eli Lilly Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Eli Lilly Radiopharmaceutical (Oral Route) Product Portfolio Table 78. Eli Lilly Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bayer Radiopharmaceutical (Oral Route) Product Portfolio Table 83. Bayer Recent Development Table 84. Triad Isotopes Company Information Table 85. Triad Isotopes Business Overview Table 86. Triad Isotopes Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Triad Isotopes Radiopharmaceutical (Oral Route) Product Portfolio Table 88. Triad Isotopes Recent Development Table 89. SIEMENS Company Information Table 90. SIEMENS Business Overview Table 91. SIEMENS Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. SIEMENS Radiopharmaceutical (Oral Route) Product Portfolio Table 93. SIEMENS Recent Development Table 94. Nordion Company Information Table 95. Nordion Business Overview Table 96. Nordion Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Nordion Radiopharmaceutical (Oral Route) Product Portfolio Table 98. Nordion Recent Development Table 99. Navidea Company Information Table 100. Navidea Business Overview Table 101. Navidea Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Navidea Radiopharmaceutical (Oral Route) Product Portfolio Table 103. Navidea Recent Development Table 104. Mallinckrodt Company Information Table 105. Mallinckrodt Business Overview Table 106. Mallinckrodt Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Mallinckrodt Radiopharmaceutical (Oral Route) Product Portfolio Table 108. Mallinckrodt Recent Development Table 109. Lantheus Company Information Table 110. Lantheus Business Overview Table 111. Lantheus Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Lantheus Radiopharmaceutical (Oral Route) Product Portfolio Table 113. Lantheus Recent Development Table 114. Jubilant Pharma Company Information Table 115. Jubilant Pharma Business Overview Table 116. Jubilant Pharma Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jubilant Pharma Radiopharmaceutical (Oral Route) Product Portfolio Table 118. Jubilant Pharma Recent Development Table 119. IBA Group Company Information Table 120. IBA Group Business Overview Table 121. IBA Group Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. IBA Group Radiopharmaceutical (Oral Route) Product Portfolio Table 123. IBA Group Recent Development Table 124. GE Healthcare Company Information Table 125. GE Healthcare Business Overview Table 126. GE Healthcare Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. GE Healthcare Radiopharmaceutical (Oral Route) Product Portfolio Table 128. GE Healthcare Recent Development Table 129. Dongcheng Company Information Table 130. Dongcheng Business Overview Table 131. Dongcheng Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Dongcheng Radiopharmaceutical (Oral Route) Product Portfolio Table 133. Dongcheng Recent Development Table 134. China Isotope & Radiation Company Information Table 135. China Isotope & Radiation Business Overview Table 136. China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Portfolio Table 138. China Isotope & Radiation Recent Development Table 139. Bracco Imaging Company Information Table 140. Bracco Imaging Business Overview Table 141. Bracco Imaging Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Bracco Imaging Radiopharmaceutical (Oral Route) Product Portfolio Table 143. Bracco Imaging Recent Development Table 144. Advanced Accelerator Applications Company Information Table 145. Advanced Accelerator Applications Business Overview Table 146. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Portfolio Table 148. Advanced Accelerator Applications Recent Development Table 149. North America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. North America Radiopharmaceutical (Oral Route) Sales by Country (2021-2026) & (K Units) Table 151. North America Radiopharmaceutical (Oral Route) Sales Market Share by Country (2021-2026) Table 152. North America Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 153. North America Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 154. North America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. North America Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 156. North America Radiopharmaceutical (Oral Route) Market Share by Country (2021-2026) Table 157. North America Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. North America Radiopharmaceutical (Oral Route) Market Share Forecast by Country (2027-2032) Table 159. Europe Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Europe Radiopharmaceutical (Oral Route) Sales by Country (2021-2026) & (K Units) Table 161. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country (2021-2026) Table 162. Europe Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 163. Europe Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 164. Europe Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Europe Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 166. Europe Radiopharmaceutical (Oral Route) Market Share by Country (2021-2026) Table 167. Europe Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Europe Radiopharmaceutical (Oral Route) Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Country (2021-2026) & (K Units) Table 171. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share by Country (2021-2026) Table 172. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 173. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 176. Asia-Pacific Radiopharmaceutical (Oral Route) Market Share by Country (2021-2026) Table 177. Asia-Pacific Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Asia-Pacific Radiopharmaceutical (Oral Route) Market Share Forecast by Country (2027-2032) Table 179. Latin America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Latin America Radiopharmaceutical (Oral Route) Sales by Country (2021-2026) & (K Units) Table 181. Latin America Radiopharmaceutical (Oral Route) Sales Market Share by Country (2021-2026) Table 182. Latin America Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 183. Latin America Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 184. Latin America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Latin America Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 186. Latin America Radiopharmaceutical (Oral Route) Market Share by Country (2021-2026) Table 187. Latin America Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Latin America Radiopharmaceutical (Oral Route) Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country (2021-2026) & (K Units) Table 191. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share by Country (2021-2026) Table 192. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032) & (K Units) Table 193. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa Radiopharmaceutical (Oral Route) Market Share by Country (2021-2026) Table 197. Middle East and Africa Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Middle East and Africa Radiopharmaceutical (Oral Route) Market Share Forecast by Country (2027-2032) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Radiopharmaceutical (Oral Route) Distributors List Table 202. Radiopharmaceutical (Oral Route) Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Radiopharmaceutical (Oral Route) Image Figure 2. Global Radiopharmaceutical (Oral Route) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceutical (Oral Route) Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceutical (Oral Route) Sales (2021-2032) & (K Units) Figure 5. Actinium-225 Image Figure 6. Global Actinium-225 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Holmium-166 Image Figure 8. Global Holmium-166 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Radium-223 Image Figure 10. Global Radium-223 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Lutetium-177 Image Figure 12. Global Lutetium-177 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Radiopharmaceutical (Oral Route) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Radiopharmaceutical (Oral Route) Market Share by Type 2025 VS 2032 Figure 17. North America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 18. North America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2025 Figure 19. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 20. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2025 Figure 23. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Radiopharmaceutical (Oral Route) Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Oncology Image Figure 30. Global Oncology Sales YoY Growth (2021-2032) & (K Units) Figure 31. Cardiology Image Figure 32. Global Cardiology Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Radiopharmaceutical (Oral Route) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Radiopharmaceutical (Oral Route) Market Share by Application 2025 VS 2032 Figure 37. North America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 38. North America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2025 Figure 39. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 40. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2025 Figure 43. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2025 Figure 47. North America Radiopharmaceutical (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Radiopharmaceutical (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Radiopharmaceutical (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Radiopharmaceutical (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Radiopharmaceutical (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Radiopharmaceutical (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Radiopharmaceutical (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Radiopharmaceutical (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Radiopharmaceutical (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Radiopharmaceutical (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Radiopharmaceutical (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Radiopharmaceutical (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Radiopharmaceutical (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Radiopharmaceutical (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Radiopharmaceutical (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Radiopharmaceutical (Oral Route) Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Radiopharmaceutical (Oral Route) Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Radiopharmaceutical (Oral Route) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Actinium-225
  • Holmium-166
  • Radium-223
  • Lutetium-177
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Eli Lilly
  • Bayer
  • Triad Isotopes
  • SIEMENS
  • Nordion
  • Navidea
  • Mallinckrodt
  • Lantheus
  • Jubilant Pharma
  • IBA Group
  • GE Healthcare
  • Dongcheng
  • China Isotope & Radiation
  • Bracco Imaging
  • Advanced Accelerator Applications

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiopharmaceutical (Oral Route) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Radiopharmaceutical (Oral Route) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Radiopharmaceutical (Oral Route) Market by Type
  6. 1.3.1 Actinium-225
  7. 1.3.2 Holmium-166
  8. 1.3.3 Radium-223
  9. 1.3.4 Lutetium-177
  10. 1.3.5 Other
  11. 1.4 Global Radiopharmaceutical (Oral Route) Market Size by Type
  12. 1.4.1 Global Radiopharmaceutical (Oral Route) Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Radiopharmaceutical (Oral Route) Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Radiopharmaceutical (Oral Route) Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Radiopharmaceutical (Oral Route) Industry Trends
  2. 2.2 Radiopharmaceutical (Oral Route) Industry Drivers
  3. 2.3 Radiopharmaceutical (Oral Route) Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceutical (Oral Route) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Radiopharmaceutical (Oral Route) Revenue (2021-2026)
  2. 3.2 Global Top Players by Radiopharmaceutical (Oral Route) Sales (2021-2026)
  3. 3.3 Global Top Players by Radiopharmaceutical (Oral Route) Price (2021-2026)
  4. 3.4 Global Radiopharmaceutical (Oral Route) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceutical (Oral Route) Major Company Production Sites & Headquarters
  6. 3.6 Global Radiopharmaceutical (Oral Route) Company, Product Type & Application
  7. 3.7 Global Radiopharmaceutical (Oral Route) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceutical (Oral Route) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceutical (Oral Route) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceutical (Oral Route) Tier 1, Tier 2, and Tier 3
4 Radiopharmaceutical (Oral Route) Regional Status and Outlook
  1. 4.1 Global Radiopharmaceutical (Oral Route) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Radiopharmaceutical (Oral Route) Historic Market Size by Region
  3. 4.2.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Radiopharmaceutical (Oral Route) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Radiopharmaceutical (Oral Route) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Radiopharmaceutical (Oral Route) Forecasted Market Size by Region
  7. 4.3.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Radiopharmaceutical (Oral Route) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Radiopharmaceutical (Oral Route) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Radiopharmaceutical (Oral Route) by Application
  1. 5.1 Radiopharmaceutical (Oral Route) Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceutical (Oral Route) Market Size by Application
  6. 5.2.1 Global Radiopharmaceutical (Oral Route) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Radiopharmaceutical (Oral Route) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Radiopharmaceutical (Oral Route) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly
  2. 6.1.1 Eli Lilly Company Information
  3. 6.1.2 Eli Lilly Business Overview
  4. 6.1.3 Eli Lilly Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly Radiopharmaceutical (Oral Route) Product Portfolio
  6. 6.1.5 Eli Lilly Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Radiopharmaceutical (Oral Route) Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Triad Isotopes
  14. 6.3.1 Triad Isotopes Company Information
  15. 6.3.2 Triad Isotopes Business Overview
  16. 6.3.3 Triad Isotopes Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Triad Isotopes Radiopharmaceutical (Oral Route) Product Portfolio
  18. 6.3.5 Triad Isotopes Recent Developments
  19. 6.4 SIEMENS
  20. 6.4.1 SIEMENS Company Information
  21. 6.4.2 SIEMENS Business Overview
  22. 6.4.3 SIEMENS Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SIEMENS Radiopharmaceutical (Oral Route) Product Portfolio
  24. 6.4.5 SIEMENS Recent Developments
  25. 6.5 Nordion
  26. 6.5.1 Nordion Company Information
  27. 6.5.2 Nordion Business Overview
  28. 6.5.3 Nordion Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nordion Radiopharmaceutical (Oral Route) Product Portfolio
  30. 6.5.5 Nordion Recent Developments
  31. 6.6 Navidea
  32. 6.6.1 Navidea Company Information
  33. 6.6.2 Navidea Business Overview
  34. 6.6.3 Navidea Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Navidea Radiopharmaceutical (Oral Route) Product Portfolio
  36. 6.6.5 Navidea Recent Developments
  37. 6.7 Mallinckrodt
  38. 6.7.1 Mallinckrodt Company Information
  39. 6.7.2 Mallinckrodt Business Overview
  40. 6.7.3 Mallinckrodt Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mallinckrodt Radiopharmaceutical (Oral Route) Product Portfolio
  42. 6.7.5 Mallinckrodt Recent Developments
  43. 6.8 Lantheus
  44. 6.8.1 Lantheus Company Information
  45. 6.8.2 Lantheus Business Overview
  46. 6.8.3 Lantheus Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lantheus Radiopharmaceutical (Oral Route) Product Portfolio
  48. 6.8.5 Lantheus Recent Developments
  49. 6.9 Jubilant Pharma
  50. 6.9.1 Jubilant Pharma Company Information
  51. 6.9.2 Jubilant Pharma Business Overview
  52. 6.9.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jubilant Pharma Radiopharmaceutical (Oral Route) Product Portfolio
  54. 6.9.5 Jubilant Pharma Recent Developments
  55. 6.10 IBA Group
  56. 6.10.1 IBA Group Company Information
  57. 6.10.2 IBA Group Business Overview
  58. 6.10.3 IBA Group Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 IBA Group Radiopharmaceutical (Oral Route) Product Portfolio
  60. 6.10.5 IBA Group Recent Developments
  61. 6.11 GE Healthcare
  62. 6.11.1 GE Healthcare Company Information
  63. 6.11.2 GE Healthcare Business Overview
  64. 6.11.3 GE Healthcare Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 GE Healthcare Radiopharmaceutical (Oral Route) Product Portfolio
  66. 6.11.5 GE Healthcare Recent Developments
  67. 6.12 Dongcheng
  68. 6.12.1 Dongcheng Company Information
  69. 6.12.2 Dongcheng Business Overview
  70. 6.12.3 Dongcheng Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dongcheng Radiopharmaceutical (Oral Route) Product Portfolio
  72. 6.12.5 Dongcheng Recent Developments
  73. 6.13 China Isotope & Radiation
  74. 6.13.1 China Isotope & Radiation Company Information
  75. 6.13.2 China Isotope & Radiation Business Overview
  76. 6.13.3 China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Portfolio
  78. 6.13.5 China Isotope & Radiation Recent Developments
  79. 6.14 Bracco Imaging
  80. 6.14.1 Bracco Imaging Company Information
  81. 6.14.2 Bracco Imaging Business Overview
  82. 6.14.3 Bracco Imaging Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bracco Imaging Radiopharmaceutical (Oral Route) Product Portfolio
  84. 6.14.5 Bracco Imaging Recent Developments
  85. 6.15 Advanced Accelerator Applications
  86. 6.15.1 Advanced Accelerator Applications Company Information
  87. 6.15.2 Advanced Accelerator Applications Business Overview
  88. 6.15.3 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Portfolio
  90. 6.15.5 Advanced Accelerator Applications Recent Developments
7 North America by Country
  1. 7.1 North America Radiopharmaceutical (Oral Route) Sales by Country
  2. 7.1.1 North America Radiopharmaceutical (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Radiopharmaceutical (Oral Route) Sales by Country (2021-2026)
  4. 7.1.3 North America Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Radiopharmaceutical (Oral Route) Market Size by Country
  6. 7.2.1 North America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026)
  8. 7.2.3 North America Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Radiopharmaceutical (Oral Route) Sales by Country
  2. 8.1.1 Europe Radiopharmaceutical (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Radiopharmaceutical (Oral Route) Sales by Country (2021-2026)
  4. 8.1.3 Europe Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Radiopharmaceutical (Oral Route) Market Size by Country
  6. 8.2.1 Europe Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Country
  2. 9.1.1 Asia-Pacific Radiopharmaceutical (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Radiopharmaceutical (Oral Route) Market Size by Country
  6. 9.2.1 Asia-Pacific Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Radiopharmaceutical (Oral Route) Sales by Country
  2. 10.1.1 South America Radiopharmaceutical (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Radiopharmaceutical (Oral Route) Sales by Country (2021-2026)
  4. 10.1.3 South America Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Radiopharmaceutical (Oral Route) Market Size by Country
  6. 10.2.1 South America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026)
  8. 10.2.3 South America Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country
  2. 11.1.1 Middle East and Africa Radiopharmaceutical (Oral Route) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Radiopharmaceutical (Oral Route) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Radiopharmaceutical (Oral Route) Market Size by Country
  6. 11.2.1 Middle East and Africa Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Radiopharmaceutical (Oral Route) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Radiopharmaceutical (Oral Route) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Radiopharmaceutical (Oral Route) Value Chain Analysis
  2. 12.1.1 Radiopharmaceutical (Oral Route) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Radiopharmaceutical (Oral Route) Production Mode & Process
  7. 12.2 Radiopharmaceutical (Oral Route) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Radiopharmaceutical (Oral Route) Distributors
  10. 12.2.3 Radiopharmaceutical (Oral Route) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst